1841 |
DCB Use in Your PCI Practice: Adjunctive Therapy or Standard of Care? |
Bruno Scheller |
Apr. 19. 24 |
1840 |
Novel Magnesium Bioresorbable Scaffold: New Insights on Next BRS Technology |
Gaku Nakazawa |
Apr. 19. 24 |
1839 |
The Future of BRS: Insights From the COMPARE-ABSORB Trial |
Pieter Smits |
Apr. 19. 24 |
1838 |
Novel Drug-Eluting Stent Designs: Not Yet Plateau, Still Need to Go!!! |
David Joel Cohen |
Apr. 19. 24 |
1837 |
DAPT Duration in Complex PCI: Unsettled or Already Established Issues? |
Duk-Woo Park |
Apr. 19. 24 |
1836 |
Long-Term Antiplatelet Management Beyond 1-Year Post-ACS or Post-PCI |
Hyo-Soo Kim |
Apr. 19. 24 |
1835 |
When to Escalate or De-Escalate in ACS/PCI |
Tullio Palmerini |
Apr. 19. 24 |
1834 |
Contemporary Best Antiplatelet Strategy in HBR or CHIP Patients: How and What? |
David Joel Cohen |
Apr. 19. 24 |
1833 |
Case 4. 0-0-1 Bifurcation PCI |
Andrejs Erglis |
Apr. 19. 24 |
1832 |
Case 3. TAP Technique for Bifurcation PCI |
Young Bin Song |
Apr. 19. 24 |